Literature DB >> 11726733

Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life.

L C Low1, S Y Tam, E Y Kwan, A M Tsang, J Karlberg.   

Abstract

Forty-eight normal full-term Chinese babies (25 boys and 23 girls) were followed up every 2 mo in the first year and every 3 mo during the second year of life for anthropometric measurements. Blood samples were taken at birth and at 6, 10, 12, and 18 mo after birth for serum GH-binding protein, IGF-I, and IGF-binding protein 3 analysis. Onset of the childhood phase of growth in the infants was determined from the growth data plotted on Infancy-Childhood-Puberty growth charts. The serum GH-binding protein concentrations were low in cord blood but rose significantly at 6 mo, with slower rises in late infancy and early childhood. However, a significant rise in serum IGF-I and IGF-binding protein 3 levels was only observed from 10 mo of life onward. The change in IGF-I between birth and 6 mo was significantly correlated with length gain (r(2) = 0.35, p < 0.05) and body mass index gain (r(2) = 0.41, p < 0.01) during the same period. The 34 infants with onset of childhood phase of growth between 6 and 10 mo had a higher mean serum IGF-I value at 10 mo (8.8 +/- 5.8 nM versus 4.9 +/- 3.1 nM; p < 0.05) and higher length velocity between 10 and 12 mo (16.3 +/- 4.7 cm/y versus 8.8 +/- 4.3 cm/y; p < 0.001) compared with the 14 infants with a later onset after 10 mo of age. A significant correlation between a change in serum IGF-I and IGF-binding protein 3 levels was observed during the three 6-mo periods between birth and 18 mo, but a significant correlation between a change in serum GH-binding protein and a change in serum IGF-I or IGF-binding protein 3 levels was only seen between 12 and 18 mo of age. The multiple regression analysis (r(2) = 0.43, p = 0.0002) revealed that the change in serum GH-binding protein and IGF-I concentrations between 6 and 12 mo of age and the age of onset of childhood phase of growth could explain 43% of the length gain between 6 and 12 mo of age in our babies. The results of our study support the hypothesis that the onset of the childhood phase of growth is associated with the onset of significant GH action on growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726733     DOI: 10.1203/00006450-200112000-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Childhood growth in boys with congenital hypogonadotropic hypogonadism.

Authors:  Tero Varimo; Matti Hero; Eeva-Maria Laitinen; Päivi J Miettinen; Johanna Tommiska; Johanna Känsäkoski; Anders Juul; Taneli Raivio
Journal:  Pediatr Res       Date:  2015-12-31       Impact factor: 3.756

2.  Effect of complementary feeding with lipid-based nutrient supplements and corn-soy blend on the incidence of stunting and linear growth among 6- to 18-month-old infants and children in rural Malawi.

Authors:  Charles Mangani; Kenneth Maleta; John Phuka; Yin Bun Cheung; Chrissie Thakwalakwa; Kathryn Dewey; Mark Manary; Taneli Puumalainen; Per Ashorn
Journal:  Matern Child Nutr       Date:  2015-12       Impact factor: 3.092

Review 3.  Interactions between Growth of Muscle and Stature: Mechanisms Involved and Their Nutritional Sensitivity to Dietary Protein: The Protein-Stat Revisited.

Authors:  D Joe Millward
Journal:  Nutrients       Date:  2021-02-25       Impact factor: 5.717

Review 4.  Measuring growth hormone and insulin-like growth factor-I in infants: what is normal?

Authors:  Colin Patrick Hawkes; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2013-12

Review 5.  Metabolic-endocrine disruption due to preterm birth impacts growth, body composition, and neonatal outcome.

Authors:  Lea Sophie Möllers; Efrah I Yousuf; Constanze Hamatschek; Katherine M Morrison; Michael Hermanussen; Christoph Fusch; Niels Rochow
Journal:  Pediatr Res       Date:  2021-05-26       Impact factor: 3.953

Review 6.  Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?

Authors:  Jesús Devesa; Cristina Almengló; Pablo Devesa
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2016-10-12

7.  Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula.

Authors:  Stefanie M P Kouwenhoven; Manja Fleddermann; Martijn J J Finken; Jos W R Twisk; Eline M van der Beek; Marieke Abrahamse-Berkeveld; Bert J M van de Heijning; Dewi van Harskamp; Johannes B van Goudoever; Berthold V Koletzko
Journal:  Nutrients       Date:  2021-04-01       Impact factor: 5.717

8.  Family Size and the Age at Infancy-Childhood Transition Determine a Child's Compromised Growth in Large Families.

Authors:  Alina German; Lisa Rubin; Galiya Raisin; Ze'ev Hochberg
Journal:  Front Pediatr       Date:  2022-04-29       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.